The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(5-(2,6-Difluorobenzylidene)-4-oxo-2-thioxothiazolidin-3-yl)-N-(4-methylpiperazin-1-yl)acetamide ID: ALA4127204
PubChem CID: 53362014
Max Phase: Preclinical
Molecular Formula: C17H18F2N4O2S2
Molecular Weight: 412.49
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CN1CCN(NC(=O)CN2C(=O)/C(=C/c3c(F)cccc3F)SC2=S)CC1
Standard InChI: InChI=1S/C17H18F2N4O2S2/c1-21-5-7-22(8-6-21)20-15(24)10-23-16(25)14(27-17(23)26)9-11-12(18)3-2-4-13(11)19/h2-4,9H,5-8,10H2,1H3,(H,20,24)/b14-9-
Standard InChI Key: KKPROWUAHDQTCH-ZROIWOOFSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
7.3010 -12.9513 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
8.1182 -12.9513 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3726 -12.1746 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.7096 -11.6924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0509 -12.1746 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7084 -10.8752 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.5978 -13.6130 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
6.2736 -11.9224 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6665 -12.4695 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1501 -11.9231 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3212 -11.1240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0987 -10.8726 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.7146 -10.5764 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.2697 -10.0735 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.0460 -9.8258 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2182 -9.0306 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6142 -8.4796 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.8352 -8.7295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6601 -9.5304 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7882 -7.6812 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8901 -12.2148 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2834 -12.7611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4534 -13.5613 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2355 -13.8123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8389 -13.2643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7213 -11.4153 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
6.6171 -13.5136 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 1 1 0
4 6 2 0
2 7 2 0
5 8 2 0
8 9 1 0
3 10 1 0
10 11 1 0
11 12 1 0
11 13 2 0
12 14 1 0
14 15 1 0
14 19 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
17 20 1 0
9 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 9 1 0
21 26 1 0
25 27 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 412.49Molecular Weight (Monoisotopic): 412.0839AlogP: 1.44#Rotatable Bonds: 4Polar Surface Area: 55.89Molecular Species: NEUTRALHBA: 6HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.41CX Basic pKa: 6.97CX LogP: 1.64CX LogD: 1.50Aromatic Rings: 1Heavy Atoms: 27QED Weighted: 0.60Np Likeness Score: -2.02
References 1. Zhang D, Markoulides MS, Stepanovs D, Rydzik AM, El-Hussein A, Bon C, Kamps JJAG, Umland KD, Collins PM, Cahill ST, Wang DY, von Delft F, Brem J, McDonough MA, Schofield CJ.. (2018) Structure activity relationship studies on rhodanines and derived enethiol inhibitors of metallo-β-lactamases., 26 (11): [PMID:29655609 ] [10.1016/j.bmc.2018.02.043 ]